Product Program year 2025 Source: CMS Open Payments

Alto Abdominal Stent Graft System

Device Cardiology/Vascular Diseases

PDI M701TVAB2380N1

Open in the dashboard

General payments

$1,951,816

9,195 payments

Research payments

$1,798,217

357 payments

Through program year 2025, $1,951,816 in general payments and $1,798,217 in research payments were reported against Alto Abdominal Stent Graft System (Cardiology/Vascular Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

9 rows
Year Kind Amount Payments
2025 General $421,838 1,698
2025 Research $499,792 84
2024 General $212,755 1,041
2024 Research $705,184 141
2023 General $322,108 1,857
2023 Research $534,092 116
2022 General $514,029 2,623
2022 Research $59,150 16
2021 General $481,086 1,976

Breakdown

Who paid General payments · program years 2021–2025
  1. Endologix, Inc. $1,951,816 9,195 payments
Top recipients General payments · program year 2025
  1. Nicolas Mouawad Vascular Surgery · West Branch, MI $28,198 7% · 34 payments
  2. Andrew Barleben Surgery · Orange, CA $27,943 7% · 39 payments
  3. John Martin Vascular Surgery · Annapolis, MD $25,530 6% · 6 payments
  4. Sonya Noor Vascular Surgery · Buffalo, NY $22,854 5% · 35 payments
  5. Anthony Feghali Vascular Surgery · Syracuse, NY $18,470 4% · 44 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $315,702 76% · 420 practitioners
  2. Surgery $53,690 13% · 46 practitioners
  3. Interventional Cardiology Internal Medicine $14,722 4% · 33 practitioners
  4. Thoracic Surgery (Cardiothoracic Vascular Surgery) $14,149 3% · 33 practitioners
  5. Cardiovascular Disease Internal Medicine $4,604 1% · 24 practitioners

The top 5 of 28 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $68,614 16% · 67 recipients
  2. Ohio $39,953 9% · 24 recipients
  3. California $38,905 9% · 47 recipients
  4. Texas $28,988 7% · 40 recipients
  5. District of Columbia $25,772 6% · 2 recipients

The top 5 of 43 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

9,195 general · 357 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record